(Q35210066)

7 August 2017

title

The effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysis (English)

1 reference

7 August 2017

1 reference

prostatic hypertrophy

1 reference

1 reference

Sean C Skeldon

1

1 reference

7 August 2017

Katy B Kozhimannil

series ordinal

2

1 reference

7 August 2017

Sumit R Majumdar

series ordinal

3

1 reference

7 August 2017

Michael R Law

series ordinal

4

1 reference

7 August 2017

publication date

23 October 2014

1 reference

Journal of General Internal Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

30

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

514-520

1 reference

Promotion of prescription drugs to consumers and providers, 2001-2010

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Use of fibrates in the United States and Canada

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

New words for old: lower urinary tract symptoms for "prostatism"

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Time to ban direct-to-consumer prescription drug marketing

13 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

Direct-to-consumer television advertising: time to turn off the tube?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

Medical management of benign prostatic hyperplasia--are two drugs better than one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

Relationship between direct-to-consumer advertising and physician diagnosing and prescribing.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Direct-to-Consumer Advertising — Education or Emotion Promotion?

26 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-014-3063-Y

The prevalence of prostatism: a population-based survey of urinary symptoms

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4371008

Direct-to-consumer advertising--strengthening our health care system

15 November 2018

1 reference

12 December 2020

Segmented regression analysis of interrupted time series studies in medication use research

1 reference

12 December 2020

Comparison of clinical trials with finasteride and dutasteride

1 reference

12 December 2020

Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions

1 reference

12 December 2020

10.1007/S11606-014-3063-Y

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference